Fertility warning
This medicine may affect fertility.
Leaflet OXALIPLATIN KABI 5mg / ml concentrate for solution for infusion
- Product code:
- W65013005
- Quantity:
- 1
- Indicated for:
- colorectal cancer
- Route of administration:
- infusion
- Substance:
- oxaliplatin (antineoplastic agent)
- ATC
- L01XA03 — Antineoplastic and immunomodulating agents | Other antineoplastic agents | Platinum compounds
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Nephrotoxicity
This medicine may affect the kidneys.
Neuropathy / neurotoxicity
This medicine may affect the nerves or nervous system.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Oxaliplatin is a chemotherapy agent used in the treatment of advanced or metastatic colorectal cancer. It works by binding to the DNA of tumor cells, inhibiting their replication and causing cell death.
The medication is administered intravenously, as directed by a doctor, usually in combination with other chemotherapy drugs. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.
Patients should be aware of potential side effects, such as peripheral neuropathy, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.
Common side effects include peripheral neuropathy, nausea, and diarrhea. In rare cases, severe reactions such as myelosuppression or allergic reactions may occur. Patients should be informed of these risks before use.
The medication is administered intravenously, as directed by a doctor, usually in combination with other chemotherapy drugs. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.
Patients should be aware of potential side effects, such as peripheral neuropathy, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.
Common side effects include peripheral neuropathy, nausea, and diarrhea. In rare cases, severe reactions such as myelosuppression or allergic reactions may occur. Patients should be informed of these risks before use.
General data about OXALIPLATIN KABI 5mg / ml
- Substance:
- oxaliplatin
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W65013005
- Concentration:
- 5mg / ml
- Pharmaceutical form:
- concentrate for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Price:
- 215.63 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.